HIV Drugs Market Size to Hit USD 66.16 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on HIV Drugs Market

5.1. COVID-19 Landscape: HIV Drugs Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global HIV Drugs Market, By Implement Type (Revenue: US$ Bn & Volume Mn Units)

8.1. HIV Drugs Market Revenue and Volume, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

8.1.1. Tillage / Soil Preparation Implement

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Sowing & Planting Implement

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Crop Maintenance & Protection Implement

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Harvesting & Post-Harvest Implement

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Material Handling, Transport & Other Implement

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global HIV Drugs Market, By Power Source

9.1. HIV Drugs Market Revenue and Volume, by Power Source

9.1.1. Powered

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Unpowered

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global HIV Drugs Market, By Mounting Type

10.1. HIV Drugs Market Revenue and Volume, by Mounting Type

10.1.1. Three-Point Hitch Mounted

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Drawbar / Trailed

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Front-Mounted

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Semi-Mounted

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global HIV Drugs Market, By Application

11.1. HIV Drugs Market Revenue and Volume, by Application

11.1.1. Land Preparation

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Sowing & Planting

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Crop Protection & Fertilizing

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Harvesting & Threshing

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Post-Harvest & Agro-Processing

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global HIV Drugs Market, By End-User Sector

12.1. HIV Drugs Market Revenue and Volume, by End-User Sector

12.1.1. Agriculture

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Non-Agriculture

12.1.2.1. Market Revenue and Volume Forecast

Chapter 13. Global HIV Drugs Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.1.2. Market Revenue and Volume Forecast, by Power Source

13.1.3. Market Revenue and Volume Forecast, by Mounting Type

13.1.4. Market Revenue and Volume Forecast, by Application

13.1.5. Market Revenue and Volume Forecast, by End-User Sector

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.1.6.2. Market Revenue and Volume Forecast, by Power Source

13.1.6.3. Market Revenue and Volume Forecast, by Mounting Type

13.1.6.4. Market Revenue and Volume Forecast, by Application

13.1.6.5. Market Revenue and Volume Forecast, by End-User Sector

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.1.7.2. Market Revenue and Volume Forecast, by Power Source

13.1.7.3. Market Revenue and Volume Forecast, by Mounting Type

13.1.7.4. Market Revenue and Volume Forecast, by Application

13.1.7.5. Market Revenue and Volume Forecast, by End-User Sector

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.2.2. Market Revenue and Volume Forecast, by Power Source

13.2.3. Market Revenue and Volume Forecast, by Mounting Type

13.2.4. Market Revenue and Volume Forecast, by Application

13.2.5. Market Revenue and Volume Forecast, by End-User Sector

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.2.6.2. Market Revenue and Volume Forecast, by Power Source

13.2.6.3. Market Revenue and Volume Forecast, by Mounting Type

13.2.7. Market Revenue and Volume Forecast, by Application

13.2.8. Market Revenue and Volume Forecast, by End-User Sector

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.2.9.2. Market Revenue and Volume Forecast, by Power Source

13.2.9.3. Market Revenue and Volume Forecast, by Mounting Type

13.2.10. Market Revenue and Volume Forecast, by Application

13.2.11. Market Revenue and Volume Forecast, by End-User Sector

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.2.12.2. Market Revenue and Volume Forecast, by Power Source

13.2.12.3. Market Revenue and Volume Forecast, by Mounting Type

13.2.12.4. Market Revenue and Volume Forecast, by Application

13.2.13. Market Revenue and Volume Forecast, by End-User Sector

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.2.14.2. Market Revenue and Volume Forecast, by Power Source

13.2.14.3. Market Revenue and Volume Forecast, by Mounting Type

13.2.14.4. Market Revenue and Volume Forecast, by Application

13.2.15. Market Revenue and Volume Forecast, by End-User Sector

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.3.2. Market Revenue and Volume Forecast, by Power Source

13.3.3. Market Revenue and Volume Forecast, by Mounting Type

13.3.4. Market Revenue and Volume Forecast, by Application

13.3.5. Market Revenue and Volume Forecast, by End-User Sector

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.3.6.2. Market Revenue and Volume Forecast, by Power Source

13.3.6.3. Market Revenue and Volume Forecast, by Mounting Type

13.3.6.4. Market Revenue and Volume Forecast, by Application

13.3.7. Market Revenue and Volume Forecast, by End-User Sector

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.3.8.2. Market Revenue and Volume Forecast, by Power Source

13.3.8.3. Market Revenue and Volume Forecast, by Mounting Type

13.3.8.4. Market Revenue and Volume Forecast, by Application

13.3.9. Market Revenue and Volume Forecast, by End-User Sector

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.3.10.2. Market Revenue and Volume Forecast, by Power Source

13.3.10.3. Market Revenue and Volume Forecast, by Mounting Type

13.3.10.4. Market Revenue and Volume Forecast, by Application

13.3.10.5. Market Revenue and Volume Forecast, by End-User Sector

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.3.11.2. Market Revenue and Volume Forecast, by Power Source

13.3.11.3. Market Revenue and Volume Forecast, by Mounting Type

13.3.11.4. Market Revenue and Volume Forecast, by Application

13.3.11.5. Market Revenue and Volume Forecast, by End-User Sector

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.4.2. Market Revenue and Volume Forecast, by Power Source

13.4.3. Market Revenue and Volume Forecast, by Mounting Type

13.4.4. Market Revenue and Volume Forecast, by Application

13.4.5. Market Revenue and Volume Forecast, by End-User Sector

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.4.6.2. Market Revenue and Volume Forecast, by Power Source

13.4.6.3. Market Revenue and Volume Forecast, by Mounting Type

13.4.6.4. Market Revenue and Volume Forecast, by Application

13.4.7. Market Revenue and Volume Forecast, by End-User Sector

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.4.8.2. Market Revenue and Volume Forecast, by Power Source

13.4.8.3. Market Revenue and Volume Forecast, by Mounting Type

13.4.8.4. Market Revenue and Volume Forecast, by Application

13.4.9. Market Revenue and Volume Forecast, by End-User Sector

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.4.10.2. Market Revenue and Volume Forecast, by Power Source

13.4.10.3. Market Revenue and Volume Forecast, by Mounting Type

13.4.10.4. Market Revenue and Volume Forecast, by Application

13.4.10.5. Market Revenue and Volume Forecast, by End-User Sector

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.4.11.2. Market Revenue and Volume Forecast, by Power Source

13.4.11.3. Market Revenue and Volume Forecast, by Mounting Type

13.4.11.4. Market Revenue and Volume Forecast, by Application

13.4.11.5. Market Revenue and Volume Forecast, by End-User Sector

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.5.2. Market Revenue and Volume Forecast, by Power Source

13.5.3. Market Revenue and Volume Forecast, by Mounting Type

13.5.4. Market Revenue and Volume Forecast, by Application

13.5.5. Market Revenue and Volume Forecast, by End-User Sector

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.5.6.2. Market Revenue and Volume Forecast, by Power Source

13.5.6.3. Market Revenue and Volume Forecast, by Mounting Type

13.5.6.4. Market Revenue and Volume Forecast, by Application

13.5.7. Market Revenue and Volume Forecast, by End-User Sector

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Implement Type (Revenue: US$ Bn & Volume Mn Units)

13.5.8.2. Market Revenue and Volume Forecast, by Power Source

13.5.8.3. Market Revenue and Volume Forecast, by Mounting Type

13.5.8.4. Market Revenue and Volume Forecast, by Application

13.5.8.5. Market Revenue and Volume Forecast, by End-User Sector

Chapter 14. Company Profiles

14.1. AbbVie Inc.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Boehringer Ingelheim International GmbH

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Bristol-Myers Squibb Company

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Cipla Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Genentech, Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Gilead Sciences, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Merck & Co., Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. ViiV Healthcare

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global HIV drugs market size is expected to increase USD 66.16 billion by 2034 from USD 38.47 billion in 2025.

The HIV drugs market is anticipated to grow at a CAGR of over 6.21% between 2025 and 2034.

The major players operating in the HIV drugs market are AbbVie Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cipla Inc., Genentech, Inc., Gilead Sciences, Inc., Merck & Co., Inc., ViiV Healthcare, and Others.

The driving factors of the HIV drugs market are the increasing prevalence of HIV/AIDS globally and development of new treatment protocols for HIV-affected individuals.

North America region will lead the global HIV drugs market during the forecast period 2025 to 2034.